Earnings Call · Q4 FY2025·2026-02-19

Q4 25EPS -11.82%·Rev n/aQ3 25EPS +2.61%·Rev n/aQ2 25EPS +1.49%·Rev n/aQ1 25EPS -2.49%·Rev n/a⚠ consensus missing

Praxis Precision Medicines, Inc. PRAX

Daniel Ferry — Investor Relations or Communications

Marcio Souza — Chief Executive Officer

Tim Kelly — Chief Financial Officer

+0.8%1d on move date+1.1% vs SPY3d+4.1%5d+5.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PRAX calls or request research access.

More PRAX calls Browse calls Request research access